144 related articles for article (PubMed ID: 35856588)
1. Chlorhexidine (di)gluconate locking device for central line infection prevention in intensive care unit patients: a multi-unit, pilot randomized controlled trial.
Pook M; Zamir N; McDonald E; Fox-Robichaud A
Br J Nurs; 2022 Jul; 31(14):S36-S46. PubMed ID: 35856588
[TBL] [Abstract][Full Text] [Related]
2. Chlorhexidine locking device for central line infection prevention in ICU patients: protocol for an open-label pilot and feasibility randomized controlled trial.
Zamir N; Pook M; McDonald E; Fox-Robichaud AE
Pilot Feasibility Stud; 2020; 6():26. PubMed ID: 32099661
[TBL] [Abstract][Full Text] [Related]
3. Control of Line Complications with KiteLock (CLiCK) in the critical care unit: study protocol for a multi-center, cluster-randomized, double-blinded, crossover trial investigating the effect of a novel locking fluid on central line complications in the critical care population.
Ornowska M; Wong H; Ouyang Y; Mitra A; White A; Willems S; Wittmann J; Reynolds S
Trials; 2022 Aug; 23(1):719. PubMed ID: 36042488
[TBL] [Abstract][Full Text] [Related]
4. Central venous access device Securement and dressing effectiveness: The CASCADE pilot randomised controlled trial in the adult intensive care.
Mitchell ML; Ullman AJ; Takashima M; Davis C; Mihala G; Powell M; Gibson V; Zhang L; Bauer M; Geoffrey Playford E; Rickard CM
Aust Crit Care; 2020 Sep; 33(5):441-451. PubMed ID: 31757717
[TBL] [Abstract][Full Text] [Related]
5. Comparison of chlorhexidine impregnated dressing and standard dressing for the prevention of central-line associated blood stream infection and colonization in critically ill pediatric patients: A randomized controlled trial.
Duyu M; Karakaya Z; Yazici P; Yavuz S; Yersel NM; Tascilar MO; Firat N; Bozkurt O; Caglar Mocan Y
Pediatr Int; 2022 Jan; 64(1):e15011. PubMed ID: 34610185
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheter insertion in preterm neonates: the ARCTIC randomised-controlled feasibility trial protocol.
Clarke P; Craig JV; Wain J; Tremlett C; Linsell L; Bowler U; Juszczak E; Heath PT
BMJ Open; 2019 Feb; 9(2):e028022. PubMed ID: 30782955
[TBL] [Abstract][Full Text] [Related]
7. Central venous Access device SeCurement And Dressing Effectiveness for peripherally inserted central catheters in adult acute hospital patients (CASCADE): a pilot randomised controlled trial.
Chan RJ; Northfield S; Larsen E; Mihala G; Ullman A; Hancock P; Marsh N; Gavin N; Wyld D; Allworth A; Russell E; Choudhury MA; Flynn J; Rickard CM
Trials; 2017 Oct; 18(1):458. PubMed ID: 28978332
[TBL] [Abstract][Full Text] [Related]
8. Bathing With 2% Chlorhexidine Gluconate: Evidence and Costs Associated With Central Line-Associated Bloodstream Infections.
Shah HN; Schwartz JL; Luna G; Cullen DL
Crit Care Nurs Q; 2016; 39(1):42-50. PubMed ID: 26633158
[TBL] [Abstract][Full Text] [Related]
9. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients.
Mimoz O; Pieroni L; Lawrence C; Edouard A; Costa Y; Samii K; Brun-Buisson C
Crit Care Med; 1996 Nov; 24(11):1818-23. PubMed ID: 8917031
[TBL] [Abstract][Full Text] [Related]
10. 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheterisation: the ARCTIC randomised controlled feasibility trial.
Clarke P; Soe A; Nichols A; Harizaj H; Webber MA; Linsell L; Bell JL; Tremlett C; Muthukumar P; Pattnayak S; Partlett C; King A; Juszczak E; Heath PT
Arch Dis Child Fetal Neonatal Ed; 2024 Feb; 109(2):202-210. PubMed ID: 37907266
[TBL] [Abstract][Full Text] [Related]
11. Polyhexamethylene biguanide discs versus unmedicated dressings for prevention of central venous catheter-associated infection in the intensive care unit: A pilot randomised controlled trial to assess protocol safety and feasibility.
Pearse I; Marsh N; Rickard CM; Ullman AJ; Larsen E; Pelecanos A; McGuinness N; Irvine L; Rapchuk IL; Ziegenfuss M; Corley A
Aust Crit Care; 2022 Sep; 35(5):512-519. PubMed ID: 34321181
[TBL] [Abstract][Full Text] [Related]
12. Evidence for the effectiveness of chlorhexidine bathing and health care-associated infections among adult intensive care patients: a trial sequential meta-analysis.
Frost SA; Hou YC; Lombardo L; Metcalfe L; Lynch JM; Hunt L; Alexandrou E; Brennan K; Sanchez D; Aneman A; Christensen M
BMC Infect Dis; 2018 Dec; 18(1):679. PubMed ID: 30567493
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy of three topical antiseptic solutions for the prevention of catheter colonization: a multicenter randomized controlled study.
Yasuda H; Sanui M; Abe T; Shime N; Komuro T; Hatakeyama J; Matsukubo S; Kawano S; Yamamoto H; Andoh K; Seo R; Inoue K; Noda E; Saito N; Nogami S; Okamoto K; Fuke R; Gushima Y; Kobayashi A; Takebayashi T; Lefor AK;
Crit Care; 2017 Dec; 21(1):320. PubMed ID: 29268759
[TBL] [Abstract][Full Text] [Related]
14. [The Incidences of Catheter Colonization and Central Line-Associated Bloodstream Infection According to Tegaderm vs. Chlorhexidine Gluconate (CHG)-Tegaderm Dressing].
Kim E; Lee H
J Korean Acad Nurs; 2020 Aug; 50(4):541-553. PubMed ID: 32895341
[TBL] [Abstract][Full Text] [Related]
15. Chlorhexidine gluconate or polyhexamethylene biguanide disc dressing to reduce the incidence of central-line-associated bloodstream infection: a feasibility randomized controlled trial (the CLABSI trial).
Webster J; Larsen E; Marsh N; Choudhury A; Harris P; Rickard CM
J Hosp Infect; 2017 Jul; 96(3):223-228. PubMed ID: 28526171
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of chlorhexidine patches on central line-associated bloodstream infections in children.
Jitrungruengnij N; Anugulruengkitt S; Rattananupong T; Prinyawat M; Jantarabenjakul W; Wacharachaisurapol N; Chatsuwan T; Janewongwirot P; Suchartlikitwong P; Tawan M; Kanchanabutr P; Pancharoen C; Puthanakit T
Pediatr Int; 2020 Jul; 62(7):789-796. PubMed ID: 32065485
[TBL] [Abstract][Full Text] [Related]
17. Results of the CHlorhexidine Gluconate Bathing implementation intervention to improve evidence-based nursing practices for prevention of central line associated bloodstream infections Study (CHanGing BathS): a stepped wedge cluster randomized trial.
Reynolds SS; Woltz P; Keating E; Neff J; Elliott J; Hatch D; Yang Q; Granger BB
Implement Sci; 2021 Apr; 16(1):45. PubMed ID: 33902653
[TBL] [Abstract][Full Text] [Related]
18. Chlorhexidine bathing in a tertiary care neonatal intensive care unit: impact on central line-associated bloodstream infections.
Quach C; Milstone AM; Perpête C; Bonenfant M; Moore DL; Perreault T
Infect Control Hosp Epidemiol; 2014 Feb; 35(2):158-63. PubMed ID: 24442078
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.
Arvaniti K; Lathyris D; Clouva-Molyvdas P; Haidich AB; Mouloudi E; Synnefaki E; Koulourida V; Georgopoulos D; Gerogianni N; Nakos G; Matamis D;
Crit Care Med; 2012 Feb; 40(2):420-9. PubMed ID: 21926583
[TBL] [Abstract][Full Text] [Related]
20. Minimising central line-associated bloodstream infection rate in inserting central venous catheters in the adult intensive care units.
Hina HR; McDowell JRS
J Clin Nurs; 2017 Dec; 26(23-24):3962-3973. PubMed ID: 28334482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
